Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Aberrant expression of CD30 in neoplastic mast cells in high-grade mastocytosis.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc - 1 Apr 2011

Sotlar Karl, Cerny-Reiterer Sabine, Petat-Dutter Karina, Hessel Harald, Berezowska Sabina, Müllauer Leonhard, Valent Peter, Horny Hans-Peter

Abstract excerpt

Systemic mastocytosis either presents as aggressive neoplasm with short survival time or indolent systemic mastocytosis with normal life expectancy. In both instances, neoplastic mast cells usually harbor the D816V-mutated variant of KIT. Phenotypically, mast cells in systemic mastocytosis usuall...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biopsy
Share to Bone Marrow
Share to Bone Marrow Examination

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Ki-1 Antigen

Share to Mast Cells

Share to Mastocytosis, Systemic

Share to Reverse Transcriptase Polymerase Chain Reaction

Share to Up-Regulation

Source

Identifiers

PMID: 21186345
DOI: 10.1038/modpathol.2010.224

Genes

KIT

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-21186345-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Aberrant expression of CD30 in neoplastic mast cells in high-grade mastocytosis.PMID 21186345Read ↗

Prevalence of CD30 immunostaining in neoplastic mast cells: A retrospective immunohistochemical study.Semantic proximity Read ↗

CD30 expression by bone marrow mast cells from different diagnostic variants of systemic mastocytosis.Semantic proximity Read ↗

Diagnosis, progression patterns and prognostication in mastocytosis.Semantic proximity Read ↗

Circulating KIT D816V mutation-positive non-mast cells in peripheral blood are characteristic of indolent systemic mastocytosis.Semantic proximity Read ↗

Advanced systemic mastocytosis: from molecular and genetic progress to clinical practice.Semantic proximity Read ↗

Mastocytosis and related disorders.Semantic proximity Read ↗

Systemic mastocytosis with associated clonal hematologic nonmast cell lineage disease: a clinicopathologic review.Semantic proximity Read ↗

Utility of KIT Mutations in Myeloid Neoplasms Without Documented Systemic Mastocytosis to Detect Hidden Mast Cells in Bone Marrow.Semantic proximity Read ↗

Clinical, immunophenotypic, and molecular characteristics of well-differentiated systemic mastocytosis.Semantic proximity Read ↗

Current state of biology and diagnosis of clonal mast cell diseases in adults.Semantic proximity Read ↗

Phenotypic heterogeneity, novel diagnostic markers, and target expression profiles in normal and neoplastic human mast cells.Semantic proximity Read ↗

Advanced systemic mastocytosis: the impact of KIT mutations in diagnosis, treatment, and progression.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.